Christine Kuepfer Selected Research

fludarabine

11/2011

Pixantrone dimaleate in combination with fludarabine, dexamethasone, and rituximab in patients with relapsed or refractory indolent non-Hodgkin lymphoma: phase 1 study with a dose-expansion cohort.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christine Kuepfer Research Topics

Disease

2	Non-Hodgkin Lymphoma (Lymphosarcoma) 07/2012 - 11/2011
2	Cardiotoxicity 07/2012 - 11/2011
2	Erectile Dysfunction 05/2006 - 02/2005
1	Neutropenia 07/2012
1	Thrombocytopenia (Thrombopenia) 07/2012
1	Leukemia 11/2011
1	Lymphoma (Lymphomas) 11/2011
1	Headache (Headaches) 05/2006
1	Dyspepsia (Indigestion) 05/2006
1	Diabetes Mellitus 05/2006

Drug/Important Bio-Agent (IBA)

2	Mitoxantrone (Novantrone)FDA LinkGeneric 07/2012 - 11/2011
2	pixantrone (BBR 2778)IBA 07/2012 - 11/2011
2	Tadalafil (Cialis)FDA Link 05/2006 - 02/2005
1	Gemcitabine FDA Link 07/2012
1	AnthraquinonesIBA 07/2012
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 07/2012
1	AnthracyclinesIBA 07/2012
1	Etoposide (VP 16)FDA LinkGeneric 07/2012
1	Ifosfamide FDA LinkGeneric 07/2012
1	Vinorelbine (Navelbine)FDA LinkGeneric 07/2012
1	fludarabineIBA 11/2011
1	Rituximab (Mabthera)FDA Link 11/2011
1	Dexamethasone (Maxidex)FDA LinkGeneric 11/2011

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 07/2012
1	Salvage Therapy 07/2012
1	Therapeutics 07/2012